Edition:
United States

Precipio Inc (PRPO.OQ)

PRPO.OQ on NASDAQ Stock Exchange Capital Market

0.34USD
18 Oct 2018
Change (% chg)

$0.01 (+3.03%)
Prev Close
$0.33
Open
$0.35
Day's High
$0.35
Day's Low
$0.32
Volume
190,093
Avg. Vol
135,124
52-wk High
$2.20
52-wk Low
$0.31

Latest Key Developments (Source: Significant Developments)

Precipio Enters Into Exchange Agreement To Restructure Remaining Legacy Accounts Payable For Approximately 20 Pct Of Original ~$5 Mln
Friday, 21 Sep 2018 09:18am EDT 

Sept 21 (Reuters) - Precipio Inc ::PRECIPIO ENTERS INTO EXCHANGE AGREEMENT TO RESTRUCTURE REMAINING LEGACY ACCOUNTS PAYABLE FOR APPROXIMATELY 20% OF ORIGINAL ~$5M.PRECIPIO INC - $82,000 MONTHLY DEBT SERVICE TO BE ELIMINATED WITH NOTES CONVERTIBLE INTO EQUITY AT A 65% PREMIUM TO MARKET.PRECIPIO INC - PAYMENTS MADE TO NOTE HOLDERS ARE FUNDED THROUGH A CONVERTIBLE NOTE WITH EXISTING INVESTORS.PRECIPIO INC - DEBT EXCHANGE RELIEVES COMPANY OF CASH PAYMENTS DUE UNDER DEBT UNTIL JULY 2019.PRECIPIO INC - RESTRUCTURING OF DEBT ELIMINATES MAJORITY OF REMAINING LIABILITIES INHERITED FROM LAST YEAR'S MERGER.  Full Article

Precipio Announces "Accelerating" Sales Of Its Pathology Services In April
Tuesday, 22 May 2018 07:37am EDT 

May 22 (Reuters) - Precipio Inc ::PRECIPIO INC - ACCELERATING SALES OF ITS PATHOLOGY SERVICES IN APRIL, INDICATING ANTICIPATED SEQUENTIAL DOUBLE DIGIT QUARTERLY SALES GROWTH.PRECIPIO - BASED ON PRELIMINARY, UNAUDITED APRIL FIGURES, OVERALL REVENUE RUN RATE FOR Q2 IS EXPECTED INCREASE BY ABOUT 30% IN APRIL COMPARED TO Q1.  Full Article

Precipio In Strategic Partnership Discussions For Proprietary Cytogenetics Media IV-Cell
Wednesday, 18 Apr 2018 07:38am EDT 

April 18 (Reuters) - Precipio Inc ::PRECIPIO IN STRATEGIC PARTNERSHIP DISCUSSIONS FOR PROPRIETARY CYTOGENETICS MEDIA IV-CELL.PRECIPIO - IN ACTIVE LICENSING DISCUSSIONS WITH SEVERAL POTENTIAL PARTNERS REGARDING IV-CELL, CO'S PROPRIETARY CYTOGENETICS MEDIA.PRECIPIO - EXTERNAL VALIDATIONS & EVALUATIONS ARE WITH COMMERCIAL DISCUSSIONS TO OUT-LICENSE RIGHTS, EXPECTED TO BE COMPLETED WITHIN CURRENT QUARTER.  Full Article

Precipio - Announces Laboratory Services Agreement With Core Diagnostics
Monday, 26 Mar 2018 07:38am EDT 

March 26 (Reuters) - Precipio Inc ::PRECIPIO - ANNOUNCES LABORATORY SERVICES AGREEMENT WITH CORE DIAGNOSTICS FOR ICE COLD-PCR LIQUID BIOPSY TESTING SERVICES IN INDIA, OTHER ASIAN COUNTRIES.PRECIPIO INC - ‍DEPENDING ON ADOPTION RATE OF LIQUID BIOPSY, ESTIMATE AN INDIA ADDRESSABLE MARKET FOR ICP OF $50 MILLION ANNUALLY​.  Full Article

Precipio Q3 sales fell 26 percent
Monday, 20 Nov 2017 04:05pm EST 

Nov 20 (Reuters) - Precipio Inc :Precipio announces third quarter 2017 financial results and provides corporate update.Q3 sales fell 26 percent.Precipio Inc - qtrly loss per common share $1.36​.  Full Article

Precipio appoints Samuel Riccitelli as Chairman, David Cohen as director
Tuesday, 14 Nov 2017 04:15pm EST 

Nov 14 (Reuters) - Precipio Inc :Precipio appoints Samuel D. Riccitelli as Chairman of the Board of Directors and elects David Cohen as director.Precipio Inc - ‍ Riccitelli replaces Robert Patzig​.  Full Article

BRIEF-Precipio Announces "Accelerating" Sales Of Its Pathology Services In April

* PRECIPIO INC - ACCELERATING SALES OF ITS PATHOLOGY SERVICES IN APRIL, INDICATING ANTICIPATED SEQUENTIAL DOUBLE DIGIT QUARTERLY SALES GROWTH